BURLINGTON, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) will present positive data from three studies of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), also referred to as TA-ER/FX006 ...
more»